A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
Clinical trial NCT03158285 · COMPLETED
Trial details
- NCT number
- NCT03158285
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-12
- Primary completion
- 2019-02-25
- Enrollment
- 741
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.